[1]
MURUGESH KANDASAMY et al. 2017. A metabolic stability determination of Tetrahydrothiazolopyridine derivative a selective 11β-hydroxy steroid dehydrogenase type 1 (11β-hsd1) inhibitor. International Journal of Pharma and Bio Sciences. 8, 3 (Sep. 2017), 120–130.